期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
肿瘤标记物CEA、SCCA、CYFRA21-1联合NSE检测对肺癌的诊断价值分析 被引量:29
1
作者 方高洁 胡娟 《实用癌症杂志》 2019年第7期1161-1163,1175,共4页
目的研究肿瘤标记物癌胚抗原(CEA)、鳞状上皮细胞癌抗原(SCCA)、细胞角蛋白19片段(CYFR A21-1)联合神经元特异性烯醇化酶(NSE)检测对肺癌的诊断价值。方法选取137例肺癌患者记为肺癌组,另取肺炎患者137例记为对照组。分别比较两组患者血... 目的研究肿瘤标记物癌胚抗原(CEA)、鳞状上皮细胞癌抗原(SCCA)、细胞角蛋白19片段(CYFR A21-1)联合神经元特异性烯醇化酶(NSE)检测对肺癌的诊断价值。方法选取137例肺癌患者记为肺癌组,另取肺炎患者137例记为对照组。分别比较两组患者血清CEA、SCCA、CYFRA21-1、NSE水平,同时分析四项肿瘤标记物诊断肺癌的敏感性与特异度,对比不同病理类型以及不同临床分期肺癌患者血清CEA、SCCA、CYFRA21-1、NSE水平。结果肺癌组患者血清CEA、SCCA、CYFRA21-1、NSE水平分别为(60. 12±32. 42) ng/ml、(4. 52±1. 23) ng/ml、(10. 12±7. 24) ng/ml、(13. 12±9. 27) ng/ml,均明显高于对照组的(2. 11±1. 62) ng/ml、(0. 78±0. 37) ng/ml、(1. 48±0. 80) ng/ml、(7. 12±2. 11) ng/ml,组间对比差异有统计学意义(P均<0. 05)。四项肿瘤标记物联合诊断肺癌的敏感性为83. 21%(114/137),明显高于四项肿瘤标记物单独诊断的敏感性,组间对比差异均有统计学意义(P均<0. 05);而各组特异度比较均不明显,组间对比差异无统计学意义(P均> 0. 05)。Ⅳ期患者CEA、SCCA、CYFRA21-1以及NSE水平均明显高于Ⅲ期,组间对比差异有统计学意义(P均<0. 05)。结论联合检测肿瘤标记物CEA、SCCA、CYFRA21-1、NSE可有效诊断肺癌,同时可为患者病情严重程度的判断提供指导作用。 展开更多
关键词 肺癌 内癌胚抗原 鳞状上皮细胞癌抗原 细胞角蛋白19片段 神经元特异性烯醇化酶
下载PDF
Utility of endoscopic ultrasound, cytology and fluid carcinoembryonic antigen and CA 19-9 levels in pancreatic cystic lesions 被引量:5
2
作者 Abdulrahman M Aljebreen Joseph Romagnuolo +1 位作者 Rafael Perini Francis Sutherland 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第29期3962-3966,共5页
AIM: To assess the diagnostic accuracy of endoscopic ultrasound (EUS), fluid tumor markers and cytology in distinguishing benign from (pre)malignant pancreatic cystic lesions. METHODS: 46 consecutive patients, referre... AIM: To assess the diagnostic accuracy of endoscopic ultrasound (EUS), fluid tumor markers and cytology in distinguishing benign from (pre)malignant pancreatic cystic lesions. METHODS: 46 consecutive patients, referred to a gastroenterologist and surgeon for a symptomatic or incidental pancreatic cyst, were reviewed. EUS, cytology, and carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) levels were compared with the final diagnosis, based on surgical pathology and/or imaging follow-up of at least 12 mo. Cysts were classified as benign (pseudocyst, serous cystadenoma) or malignant/ pre-malignant (mucinous cystic neoplasm). Receiver- operator characteristics (ROC) curve analysis was performed. RESULTS: The mean age was 56 years; 29% were male and median cyst diameter was 3 cm. Final outcome was obtained in 41 (89%) patients. Twenty-three (56%) of these 41 had surgical pathology. Twenty-three (56%) had benign lesions and 18 (44%) had malignant/pre- malignant lesions. Sensitivity, specificity and positive and negative predictive value of EUS alone to distinguish benign from malignant/premalignant pancreatic cystic lesions were 50%, 56%, 36% and 54% and for cytology were 71%, 96%, 92% and 85%, respectively. The corresponding values for the ROC-derived ideal cutoffswere 75%, 90%, 75%, 90% for CA 19-9 (> 37 U/mL) and 70%, 85%, 79% and 78% for CEA (> 3.1 ng/mL). Subgroup analysis of those with surgical pathology yielded almost identical performance and cutoffs. CONCLUSION: Cytology and cyst fluid tumor marker analysis is a very useful tool in distinguishing benign from (pre)malignant pancreatic cystic lesions. 展开更多
关键词 Endoscopic ultrasound Carcinoembryonic antigen CA 19-9 Pancreatic cystic lesions Fine needle aspiration
下载PDF
Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma 被引量:4
3
作者 Jing Xu Yasunori Sato +5 位作者 Kenichi Harada Norihide Yoneda Yasuni Nakanuma Teruyuki Ueda Atsushi Kawashima Akishi Ooi 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第14期1923-1926,共4页
A case of intraductal papillary neoplasm of the bile duct (IPNB) arising in a patient with hepatitis B-related liver cirrhosis with hepatocellular carcinoma (HCC) is reported. A 76-year-old man was admitted to our hos... A case of intraductal papillary neoplasm of the bile duct (IPNB) arising in a patient with hepatitis B-related liver cirrhosis with hepatocellular carcinoma (HCC) is reported. A 76-year-old man was admitted to our hospital with recurrent HCC. Laboratory data showed that levels of carcinoembryonic antigen and carbohydrate antigen 19-9 were elevated. He died of progressive hepatic failure. At autopsy,in addition to HCCs,an intraductal papillary proliferation of malignant cholangiocytes with fibrovascular cores was found in the dilated large bile ducts in the left lobe,and this papillary carcinoma was associated with an invasive mucinous carcinoma (invasive IPNB). Interestingly,extensive intraductal spread of the cholangiocarcinoma was found from the reactive bile ductular level to the interlobular bile ducts and septal bile ducts and to the large bile ducts in the left lobe. Neural cell adhesion molecule,a hepatic progenitor cell marker,was detected in IPNB cells. It seems possible in this case that hepatic progenitor cells located in reactive bile ductules in liver cirrhosis may have been responsible for the development of the cholangiocarcinoma and HCC,and that the former could have spread in the intrahepatic bile ducts and eventually formed grossly visible IPNB. 展开更多
关键词 Papillary carcinoma Bile duct neoplasms Liver cirrhosis Progenitor cells Hepatocellular carcinoma Neural cell adhesion molecules
下载PDF
伊立替康与替吉奥联合用药对晚期结肠癌患者的影响 被引量:1
4
作者 肖佳 罗盘 周强 《实用中西医结合临床》 2020年第17期42-43,共2页
目的:探讨伊立替康与替吉奥联合用药对晚期结肠癌患者血清内癌胚抗原、糖链抗原50、糖链抗原199水平影响。方法:选取2018年4月~2019年4月收治的64例晚期结肠癌患者为研究对象,随机分为对照组和观察组,各32例。对照组给予FOLFIRI方案治疗... 目的:探讨伊立替康与替吉奥联合用药对晚期结肠癌患者血清内癌胚抗原、糖链抗原50、糖链抗原199水平影响。方法:选取2018年4月~2019年4月收治的64例晚期结肠癌患者为研究对象,随机分为对照组和观察组,各32例。对照组给予FOLFIRI方案治疗,观察组给予伊立替康与替吉奥联合治疗,对比两组临床疗效、治疗前后血清内癌胚抗原、糖链抗原50、糖链抗原199水平和不良反应发生情况。结果:观察组部分缓解、疾病控制率分别为50.00%、84.38%,显著高于对照组的25.00%、56.25%(P<0.05);两组治疗后血清内癌胚抗原、糖链抗原50、糖链抗原199水平均较治疗前降低,且观察组低于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:伊立替康与替吉奥联合治疗晚期结肠癌疗效满意,可显著降低患者血清内癌胚抗原、糖链抗原50、糖链抗原199水平。 展开更多
关键词 晚期结肠癌 伊立替康 替吉奥 糖链抗原50 内癌胚抗原
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部